HEXO

7 Marijuana Stocks to Watch as the Presidential Election Approaches

Marijuana stocks are already getting buying interest ahead of the major event

Stock Market Today: Apple’s New iPhone; Abbott’s New Coronavirus Test

Apple launched a new iPhone, while the earnings reports continue to trickle in. Here's what happened in the stock market today.

Hexo Earnings: HEXO Stock Slides 28% on Q2 Results

Hexo (HEXO) earnings for the Canadian cannabis company's fiscal second quarter of 2020 have HEXO stock taking a beating on Monday.

3 Marijuana Stocks to Avoid at All Costs

Marijuana stocks are looking like a good play for this year, but these three companies are not worth taking a risk on in 2020.

30 Marijuana Stocks to Buy as the Future Turns Green

Thanks to favorable public sentiment and political tailwinds, the list of marijuana stocks to buy is both extensive and diverse.

30 Marijuana Stocks to Buy as the Future Turns Green

Thanks to favorable public sentiment and political tailwinds, the list of marijuana stocks to buy is both extensive and diverse.

Hexo Stock May Bottom Here, but It Probably Won’t

Pot stocks will rebound in 2020, but HEXO stock may not join the party, as growth trends remain pressured by competition.

5 Not-So-Hot Stocks to Sell in 2020

While markets may roar to all-time highs in 2020, these five stocks likely will miss the party and are stocks to sell in the new year.

Hexo Stock Is Sick — Go With Other Cannabis Plays Instead

Hexo stock continues to fall, making new lows while its peers have so far refrained. Avoid Hexo as a result.

Hexo Stock Is in a Race Against Time

Hexo stock has fallen just over 80% as it waits for Cannabis 2.0 to take root. However, after a year of overpromising, investors' patience is thin.

What Hexo Stock Needs Is Some Old-Fashioned Reaganomics

Last year was a year of reckoning for Hexo stock and the broader cannabis market. However, most of the pain may have resulted from unnecessary government inefficiencies.

Hexo Hoping to Recover With Cannabis 2.0 Boom in 2020

With Cannabis 2.0 in the works, Hexo’s risk-reward profile is beginning to look very favorable for investors willing to stick their necks out. Here’s why.

It Doesn’t Look as If 2020 Will Be Any Better for Hexo Stock

Cash burn will result in equity dilution. Slower growth likely in medicinal and recreational cannabis due to regulatory headwinds.

Earnings Will Be Critical for Hexo Stock

Hexo has significant growth and balance sheet problems. A strong Q1 report won't fix those issues, but could inspire confidence in a turnaround.

Why Investors Should Continue to Say No to Hexo Stock

At the end of the day, the cannabis industry will birth only 5 to 10 big winners, and HEXO stock likely won't be one of them.

Hexo? Heck No! Just Avoid Hexo Stock for Now

I'm still bullish on marijuana stocks, but I won't let Hexo stock weigh down my portfolio.

Is the Right Move to Buy Hexo Stock Amid Cannabis Rebound?

Hexo stock is showing improvement on the charts, but we need a significant improvement given the lacking fundamentals and industry disdain.

Hexo Stock Is a Falling Knife That Could See a Few Dead Cat Bounces

Hexo stock is a falling knife. But the rollout of a discount dried flower product and infused beverages could mean more "dead cat bounces."

Sell Any Bounce in Hexo Stock After Massive Earnings Flop

Like many of its marijuana peers, Hexo stock gave investors a terrible earnings report this quarter. And things aren't getting better anytime soon.